Impaired chylomicron remnant clearance in familial combined hyperlipidemia.
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Postprandial chylomicron remnant clearance was studied in six patients with familial combined hyperlipidemia (FCH) and seven control subjects by using an oral retinyl palmitate (RP) fat-loading test. The chylomicron remnant clearance (Sf < 1,000 fraction), expressed as the area under the RP curve (AUC-RP), was delayed in FCH subjects (65.05 +/- 12.84 hours x [mg/L]) compared with control subjects (25.1 +/- 5.4 hours x [mg/L]; p = 0.01). Postprandial lipoprotein particle size and composition in the Sf > 1,000 fraction were different between FCH and control subjects as analyzed by molecular-sieve chromatography. Fasting high density lipoprotein cholesterol was lower in FCH patients (0.54 +/- 0.09 mmol/L) than in control subjects (0.89 +/- 0.05 mmol/L; p < 0.01). Mean plasma postheparin lipoprotein lipase and hepatic lipase activities were similar between FCH patients (94 +/- 25 and 427 +/- 57 milliunits/mL, respectively) and control subjects (126 +/- 16 and 362 +/- 33 milliunits/mL, respectively). In FCH, a 54% reduction (p < 0.05) of plasma triglycerides to 2.63 +/- 0.41 mmol/L by drug treatment resulted in an enhanced, but not normalized, clearance of chylomicron remnants (39.4 +/- 6.0 hours x [mg/L]). Univariate regression analysis revealed that in FCH subjects the changes in fasting plasma apolipoprotein C-III concentrations after therapy were significantly associated with the changes in chylomicron remnant AUC-RP (r = 0.87; p = 0.02). Delayed elimination of atherogenic chylomicron remnants may contribute to the increased risk of premature atherosclerosis in FCH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L. (1990) · Science · doi:10.1126/science.2167514 · Cited by 539
Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107334 · Cited by 484 · cited 3×
“'(41) This has been explained by the common lipolytic route for VLDLs and chylomicrons.(24) The present findings support this mechanism, since a 54% reduction in plasma TG concentration in FCH subjects resulted in a 39% improvement of chylomicron remnant RP removal.”
BackgroundResultInfluentialGinsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424 · cited 1×
“-(31) The elimination of chylomicron remnants is predominantly dependent on apo E ligand function,(25) the putative apo E receptor (LDL receptor-related protein),(26) LPL protein binding,(32) HL activity,(33) and inhibitory factors like the apo C proteins.(34)-(36) The apo B/E receptor may also bind remnant particles…”
BackgroundPatsch, J. R., Karlin, J. B., Scott, L. W., Smith, L. C., & Gotto, A. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1449 · Cited by 386
Weintraub, M. S., Zechner, R., Brown, A., Eisenberg, S., & Breslow, J. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113806 · Cited by 331 · cited 1×
“Dietary studies in normal humans have revealed that changes in plasma TG concentrations influence chylomicron remnant removal.(40)'(41) This has been explained by the common lipolytic route for VLDLs and chylomicrons.”
BackgroundBlankenhorn, D. H., Alaupovic, P., Wickham, E., Chin, H. P., & Azen, S. P. (1990) · Circulation · doi:10.1161/01.cir.81.2.470 · Cited by 278 · cited 1×
“In addition, elevated apo C-III concentrations have been associated with an increased risk for myocardial infarction in the Cholesterol-Lowering Atherosclerosis Study.(48) The S2 minor allele of the apo C-III gene was significantly more frequent in subjects with atherosclerosis compared with control subjects.”
BackgroundWeintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261 · cited 3×
“It has been reported by many authors that the magnitude of the postprandial lipemia (the TG response) depends on the fasting plasma TG.(10)'(13)'(1523) Several mechanisms may be responsible for the relatively delayed chylomicron TG catabolism in FCH.”
BackgroundMethodResultInfluentialCohn, J. S., McNamara, J. R., Cohn, S. D., Ordovas, J. M., & Schaefer, E. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38485-6 · Cited by 195
Cited by
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
“the major cause of the other lipid abnormalities since it will lead to delayed clearance of the TG-rich lipoproteins [34–48] and formation of small dense LDL [48,49].”
BackgroundSelf-citationHepatic uptake of chylomicron remnants
Cooper, A. D. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34932-4 · Cited by 499
Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism
Lopez-Miranda, J., Williams, C., & Lairon, D. (2007) · British Journal of Nutrition · doi:10.1017/s000711450774268x · Cited by 320
Zilversmit, D. B. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.153 · Cited by 262
Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201
Metadata
- Authors
- Cabezas, M. C., de Bruin, T. W., Jansen, H., Kock, L. A., Kortlandt, W., & Erkelens, D. W.
- Venue
- Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Published
- 1993-06
- Volume
- 13
- Issue
- 6
- Pages
- 804-814
- ISSN
- 1049-8834 (ISSN-L)
- OpenAlex
- W2023363909
- Cited by
- 125
- References
- 11
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired chylomicron remnant clearance in familial combined hyperlipidemia. https://app.cochat.ai/papers/10.1161/01.atv.13.6.804
- The paper
- Cabezas, M. C., de Bruin, T. W., Jansen, H., Kock, L. A., Kortlandt, W., & Erkelens, D. W. (1993). Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. https://doi.org/10.1161/01.atv.13.6.804
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.